Martin, Anne-Céline http://orcid.org/0000-0002-6148-3523
Benamouzig, Robert
Gouin-Thibault, Isabelle
Schmidt, Jeannot
Funding for this research was provided by:
Pfizer and Bristol Myers Squibb
Article History
Accepted: 5 April 2023
First Online: 5 May 2023
Declarations
:
: Anne-Céline Martin: BMS/Pfizer, Bayer, Boehringer Ingelheim, Astra Zeneca, Novartis. Robert Benamouzig: no relevant conflicts of interest to declare. Isabelle Gouin-Thibault: Alliance BMS/Pfizer, Bayer, Leo Pharma, Abbvie. Jeannot Schmidt: no relevant conflicts of interest to declare.
: Medical writing assistance was funded by Pfizer and Bristol Myers Squibb.
: Not applicable.
: Not applicable.
: Not applicable.
: Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
: Not applicable.
: The content of this manuscript was originally based on discussions during expert meetings including all the authors. All authors critically reviewed the outline and first draft of the manuscript and have read and approved the final manuscript for submission.